Rebecca Chamberlain

Rebecca Chamberlain is a Senior Scientist at Adaptimmune with experience in T-cell Process Development. Prior to this role, Rebecca worked as a Postdoctoral Research Associate at The Open University, where Rebecca focused on functional genomics and analyzed large clinical datasets. Rebecca holds a Ph.D. in Deacetylation of GD3A as a Potential Therapeutic Strategy for Paediatric Medulloblastoma from the University of Portsmouth. Rebecca also has a Bachelor's Degree in Pharmacology from the same university.